Key result
Brain damage during cardiopulmonary bypass may be induced by activation of the clotting system and release of glycerol, as indicated by significant correlations between S100b, F1+2, and glycerol.
Why the study?
What are the mechanisms of neurological damage in patients undergoing cardiac surgery with cardiopulmonary bypass?
Observational (n=100)
What are the mechanisms of neurological damage in patients undergoing cardiac surgery with cardiopulmonary bypass?
Neurological complications following cardiopulmonary bypass are likely caused by a combination of cerebral hypoperfusion, systemic inflammation, and microembolization from coagulation and fat release.
Answers are grounded in this paper and cite their sources.
Correlations implicate coagulation activation in bypass-related brain injury; hypothesis-generating and should not yet change practice.
Cardiac surgery with cardiopulmonary bypass (CPB) has been associated with a higher risk of neurologic and neuropsychological deficits than other major types of surgery [ 1 ]. Different etiologic mechanisms have been proposed to account for these deficits [ 2 , 3 , 4 , 5 ]. First, inadequate perfusion of the brain circulation has been proposed as a factor of brain damage. Second, CPB produces a systemic inflammatory response that may give rise to renal and pulmonary dysfunction, but the effect on the brain has attracted less attention [ 6 , 7 ]. Although a causal relationship has been suggested between the inflammatory response and cognitive dysfunction [ 8 ], no clear evidence exists. Third, emboli are formed during CPB by air, clotting activity or cell aggregation and fat release. Partly, these emboli are captured by the various filters in the circuit, but reorganization of smaller emboli might still occur. By comparing several studies in which markers for brain damage were used, these three major mechanisms are discussed.
No takes yet. Share an insight, caveat, or question.
Willem van Oeveren (2000) conducted an observational in Coronary artery disease requiring bypass grafting (n=100). Cardiopulmonary bypass was evaluated on Correlation between S100b release and markers of inflammation, clotting, and fat release. Brain damage during cardiopulmonary bypass may be induced by activation of the clotting system and release of glycerol, as indicated by significant correlations between S100b, F1+2, and glycerol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: